$HLF

L'Helias Sophie purchased $14K of HLF

L'Helias Sophie purchased 1,200 shares of HERBALIFE LTD. (HLF) at $11.31 on 2026-06-04.

Original reporting
SEC EDGAR · L'Helias Sophie
Published Jun 4, 2026, 10:33 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 4, 2026, 10:36 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$HLF
Neutral
medium confidence
Mentioned
$HLF
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$HLFNeutralLow
01

Why it matters

This provides a fresh datapoint on insider behavior but does not introduce new company fundamentals (no guidance, financial results, or deal terms).

02

Market read

Traders may note the buy as a minor bullish sentiment input, but it is unlikely to be a standalone driver of price action.

03

What to watch

Transaction size is small and lacks accompanying narrative; without follow-on buys or operational news, signal-to-noise is low.

Relevance 6/10Novelty 6/10Timing: SEC Form 4 filed today (2026-06-04)

Background

The article is an SEC insider transaction disclosure (Form 4) showing a director’s open-market purchase of HLF shares.

Company-level read

Ticker impact

$HLFNeutralMedium confidence
Context

Director L'Helias Sophie bought 1,200 shares of Herbalife (HLF) in an open-market transaction disclosed via SEC Form 4 on 2026-06-04.

Expected impact

Limited near-term impact; any effect is likely short-lived unless followed by additional buying or company-specific news.

Evidence & confidence

The filing is an insider transaction (not earnings/guidance/M&A). The disclosed size (~$13.6k) is relatively small, and there is no 10b5-1 plan pre-arrangement noted, but insider buys alone rarely drive sustained repricing.

Market effects

Minimal; this is company-specific insider activity with no stated sector/regulatory trigger.

None indicated.

None indicated.

Counterpoint

Insider buys can be routine diversification or personal liquidity decisions and may not reflect a change in business outlook.

Key entities

  • HERBALIFE LTD.

    Public company whose director disclosed an open-market purchase of shares via SEC Form 4.

  • L'Helias Sophie

    Director who purchased 1,200 shares of HLF at $11.31/share on 2026-06-04.

Related articles

$HLFMedAI 8/10

Herbalife (NYSE:HLF) Beats Q2 CY2026 Sales Expectations

Herbalife (NYSE:HLF) reported Q2 CY2026 revenue of $1.33 billion, up 5.4% year on year and about 1.5% above Wall Street estimates, according to the company. It guided next-quarter revenue near $1.31 billion. Non-GAAP EPS was $0.51, missing consensus by 4.9%. Shares fell 3.4% to $12.16 after results.

$HLFMed

HERBALIFE LTD. (HLF): Results of Operations and Financial Condition

HERBALIFE LTD. (HLF) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ea030059301ex99-1.htm PRESS RELEASE ISSUED BY HERBALIFE LTD. ON AUGUST 5, 2026 Exhibit 99.1 CONFIDENTIAL & PRIVILEGED Herbalife Reports Second Quarter Net Sales Growth; Marks Fourth Consecutive Quarter of Topline Expansion; Net Sales and Adjusted EBITDA 1 Exceed Guidanc